Table 2.
Clinical characteristics and fasting serum adipocyte fatty acid binding protein levels of 165 diabetic patients.
| Characteristic | Number (%) | A-FABP (ng/mL) | P value | |
|---|---|---|---|---|
| Gender | Male | 92 (55.7) | 23.90 ± 12.44 | <0.001∗ |
| Female | 73 (44.3) | 34.27 ± 17.16 | ||
| Hypertension | No | 79 (47.9) | 26.16 ± 15.49 | 0.065 |
| Yes | 86 (52.1) | 30.63 ± 15.38 | ||
| Smoking | No | 148 (89.7) | 28.54 ± 15.55 | 0.907 |
| Yes | 17 (10.3) | 28.07 ± 16.03 | ||
| Statin | No | 84 (50.9) | 26.83 ± 13.07 | 0.164 |
| Yes | 81 (49.1) | 30.21 ± 17.68 | ||
| Fibrate | No | 156 (94.5) | 28.14 ± 15.73 | 0.229 |
| Yes | 9 (5.5) | 34.57 ± 10.78 | ||
| Metformin | No | 74 (44.8) | 28.47 ± 16.54 | 0.986 |
| Yes | 91 (55.2) | 28.51 ± 14.79 | ||
| Sulfonylureas | No | 77 (46.7) | 29.07 ± 16.50 | 0.654 |
| Yes | 88 (53.3) | 27.98 ± 14.75 | ||
| DDP-4 inhibitor | No | 65 (39.4) | 28.03 ± 17.09 | 0.763 |
| Yes | 100 (60.6) | 28.79 ± 14.54 | ||
| Thiazolidinediones | No | 160 (97.0) | 28.26 ± 14.60 | 0.282 |
| Yes | 5 (3.0) | 35.88 ± 37.05 | ||
| Insulin | No | 122 (73.9) | 28.39 ± 15.68 | 0.887 |
| Yes | 43 (26.1) | 28.78 ± 15.34 | ||
Data are expressed as means ± standard deviations.
∗ P < 0.05 was considered statistically significant after Student's t-test.
DDP-4, dipeptidyl peptidase 4.